Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Severe pulmonary sarcoidosis].

H Nunes1, C Maurer, J M Naccache

  • 1Fédération des Maladies Respiratoires et Thoraciques de l'Adulte, Hôpital Avicenne, 125, rue de Stalingrad, 93009 Bobigny.

Annales De Medecine Interne
|May 18, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Emergency room visits for asthma and the reported outcomes: The PASS survey by the CRISALIS network].

Revue des maladies respiratoires·2025
Same author

Complete response to mTOR inhibitor following JAKi failure in severe pulmonary sarcoidosis.

Pulmonology·2024
Same author

Treatment of a symptomatic cervical cerebrospinal fluid fistula after full endoscopic cervical foraminotomy with CT-guided epidural fibrin patch.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2023
Same author

The FRESH Study: Treatment of Intracranial Aneurysms with the New FRED X Flow Diverter with Antithrombotic Surface Treatment Technology-First Multicenter Experience in 161 Patients.

AJNR. American journal of neuroradiology·2023
Same author

[Lung transplantation for sarcoidosis].

Revue des maladies respiratoires·2023
Same author

[Updated indications and contraindications in 2022 for lung transplantation in France].

Revue des maladies respiratoires·2022

Sarcoidosis frequently affects the lungs, with half of patients developing respiratory complications like fibrosis or insufficiency. Treatments offer temporary relief, but lung transplantation may be needed for severe cases.

Area of Science:

  • Pulmonology
  • Immunology
  • Radiology

Context:

  • Sarcoidosis commonly presents with mediastinal and pulmonary involvement in 90% of patients.
  • While many cases are mild and reversible, a significant portion develops respiratory complications.

Purpose:

  • To outline the spectrum of respiratory complications in sarcoidosis.
  • To describe the impact of computed tomography (CT) findings on disease course and functional impairment.
  • To evaluate treatment efficacy and the role of lung transplantation.

Summary:

  • Respiratory complications, including interstitial lung disease, airway obstruction, and pulmonary fibrosis, occur in 50% of sarcoidosis patients.
  • CT patterns correlate with functional deficits and disease progression; chronic obstructive insufficiency and cor pulmonale are noted.

Related Experiment Videos

  • Respiratory issues contribute to mortality, particularly in advanced stages (III-IV); corticosteroids provide symptomatic control, and transplantation is an option for refractory cases.

    • Impact:

    • Highlights the significant morbidity and mortality associated with sarcoidosis-related respiratory manifestations.
    • Emphasizes the importance of early diagnosis, monitoring, and tailored treatment strategies.
    • Informs clinical decision-making regarding the management of severe sarcoidosis and the consideration of lung transplantation.